Protara Therapeutics (1KPA.F) Q3 2024 Earnings

6AugConfirmed
Q2 2024
Q3 2024
-0.9
-0.74
-0.58
-0.41

Details

Expected EPS
-0.732208
Actual EPS
-0.411867
Surprise EPS
0.32
Surprise Percent
+43.75%

Description

Protara Therapeutics (1KPA.F) has reported earnings of -0.411867 per share for Q3 2024.

0 Comments

Share your thoughts